Navigation Links
Profarma's Gross Revenues Reached R$ 698.2 Million in the 3rd Quarter 2007, a 31.9% Growth Over the Same Period Last Year and Net Income Rose by 94.9%, Respectively

RIO DE JANEIRO, Brazil, Nov. 5 /PRNewswire-FirstCall/ -- One of Brazil's leading distributors of pharmaceutical products, Profarma Distribuidora de Produtos Farmaceuticos S.A. ("Profarma" or the "Company") (Bovespa: PFRM3) has just announced its results for the third quarter of 2007 (3Q07). Profarma's financial statements are prepared in accordance with Brazilian Corporate Legislation, with the financial and operational information being prepared on consolidated bases in accordance with Brazilian Generally Accepted Accounting Principles (BR GAAP) and compared with the same period of 2006 (3Q06).

Profarma's non-financial information has not been revised by the external auditors.


-- Profarma's market share breaks record and reaches 12.0%, which is

1.3 percentage points above the share achieved in 2Q07.

-- Growth of 31.9% in consolidated Gross Revenues, reaching R$ 698.2

million, well above the figures for the same period in 2006.

-- Growth of 94.9% in Net Income, reaching R$ 8.2 million, when compared

to 3Q06.

-- Adjusted EBITDA was R$ 21.6 million for 3Q07, growth of 12.9% in

relation to the R$ 19.1 million posted in 3Q06.

-- Cash cycle reduce by 2 days in relation to the previous quarter.

-- New regions of Pernambuco (PE), Ceara (CE) and Rio Grande do Sul (RS)

showed strong growth in relation to 2Q07, achieving Gross Revenues of

R$ 55.7 million.

-- Reduction of 29.0% in errors per million units shipped, dropping from

204.3 recorded in 2Q07 to 145.0 in 3Q07.



Tuesday, November, 06th, 2007

10:00 a.m. (Brazil)

07:00 a.m. (NY)

Telephone: +55 (11) 2101-4848

Replay: +55 (11) 2101-4848



Tuesday, November, 06th, 2007

12:00 a.m. (Brazil)

09:00 a.m. (NY)

Telephone: +1 (973) 935-8893

Replay: +1 (973) 341-3080

Code: 9313688


Max Fischer


Telefone: +55(21) 4009-0276,

Fax: +55(21) 2491-3906


SOURCE Profarma Distribuidora de Produtos Farmaceuticos S.A.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
2. Grosse Pointes Cottage Hospital Joins Henry Ford Health System
3. inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
4. Memry Corporation FY 2007 Revenues $51.7M; Net Income $317,000 or $0.01 Per Share
5. Biotel Announces Record Revenues and Strong Earnings for the Fourth Quarter and Year Ended June 30, 2007
6. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
7. Immucor Announces Record Fiscal First Quarter Revenues
8. Volcano Corporation Reports Preliminary Third Quarter 2007 Revenues
9. Nyer Medical Group, Inc. Reports EPS of $.02 on Record Revenues of $69.9 Million for Fiscal Year Ended 2007
10. Aspreva Announces Preliminary Revenues for Third Quarter 2007
11. Nexia Closes Acquisition of Green Endeavors; Landis Salons On Track to Generate Revenues of $2.2 Million in 2007
Post Your Comments:
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... named one of Michigan’s 2017 Best and Brightest in Wellness® by Best and ... Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)...  EpiVax, Inc., a leader in the fields ... announced the launch of EpiVax Oncology Inc., a ... cancer vaccines. EpiVax has provided $500,000 in seed ... technologies to the new precision immunotherapy venture. Gad ... as Chief Executive Officer. Gad brings over 25 ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
Breaking Medicine Technology: